97-5596. Notice Pursuant to the National Cooperative Research and Production Act of 1993 Consortium for Plasma Science, LLC

[Federal Register Volume 62, Number 45 (Friday, March 7, 1997)]
[Notices]
[Page 10584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-5596]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993 Consortium for Plasma Science, LLC

    Notice is hereby given that, on February 5, 1997, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), the Consortium for Plasma 
Science, LLC has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) the 
identities of the parties and (2) the nature and objective of the 
venture. The notifications were filed for the purpose of invoking the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Pursuant to Section 6(b) 
of the Act, the identities of the parties are Alpha Therapeutic 
Corporation, Los Angeles, CA; Baxter Healthcare Corporation, Deerfield, 
IL; Bayer Corporation, West Haven CN; Centeon L.L.C., King of Prussia, 
PA; and NABI, Boca Raton, CA. The general area of planned activity is 
to develop, promote and conduct research and development to address 
improvements in safety in blood plasma and blood plasma products.
Constance K. Robinson,
Director of Operations Antitrust Division.
[FR Doc. 97-5596 Filed 3-6-97; 8:45 am]
BILLING CODE 4410-11-M